Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-14 5:52 pm Sale | 2025-05-12 | 13D | BridgeBio Pharma, Inc. BBIO | KKR Genetic Disorder L.P. | 13,260,971 7.000% | -6,000,000 (-31.15%) | Filing History |
| 2025-03-07 6:15 pm Sale | 2025-03-05 | 13D | BridgeBio Pharma, Inc. BBIO | KKR Genetic Disorder L.P. | 19,260,971 10.100% | -6,000,000 (-23.75%) | Filing History |
| 2024-09-17 6:41 pm Sale | 2024-09-13 | 13D | BridgeBio Pharma, Inc. BBIO | KKR Genetic Disorder L.P. | 25,260,971 13.400% | -5,800,000 (-18.67%) | Filing History |
| 2021-02-17 5:28 pm Sale | 2020-02-11 | 13D | BridgeBio Pharma, Inc. BBIO | KKR Genetic Disorder L.P. | 31,060,971 20.900% | -3,450,000 (-10.00%) | Filing History |